# Expanded Access for CC-4047

> **NCT03723096** · — · NO_LONGER_AVAILABLE · sponsor: **Celgene**

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** CC-4047

## Key facts

- **NCT ID:** NCT03723096
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2018-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03723096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03723096, "Expanded Access for CC-4047". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03723096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*